Changes of HbA1c variability after the switch to a longer‐acting insulin analog in people with type 1 diabetes
ABSTRACT This study investigated whether longer‐acting basal analogs (insulin degludec and insulin glargine U300) could reduce visit‐to‐visit hemoglobin A1c (HbA1c) variability in patients with type 1 diabetes. Ninety adults with type 1 diabetes for whom the basal insulin was switched to a longer‐ac...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wiley
2023-02-01
|
| Edice: | Journal of Diabetes Investigation |
| Témata: | |
| On-line přístup: | https://doi.org/10.1111/jdi.13941 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|